Background: Anterior cervical discectomy and fusion (ACDF) and cervical disc arthroplasty (CDA) have been used to treat degenerative disc disease at single as well as multiple cervical levels. This study compares the safety and efficacy of 1-level versus 2-level CDA and ACDF.
INTRODUCTION
Anterior cervical discectomy and fusion (ACDF) has been the traditional treatment for degenerative conditions of the cervical spine. Cervical disc arthroplasty (CDA) is an established safe and effective alternative treatment of cervical pathology. In the United States, CDA has been approved for use at a single level or 2 contiguous levels. To control for the surgical and biomechanical differences between single-and multilevel pathology, clinical trials have directly compared single-level ACDF to single-level CDA [1] [2] [3] [4] [5] [6] and multilevel ACDF to multilevel CDA. [7] [8] [9] [10] While most patients suffer from multilevel spine pathology, 7 the safety and effectiveness of cervical surgery may be affected by the number of treated levels. Biomechanical studies have demonstrated that cervical fusion increases intradiscal pressure and segmental motion at the adjacent segments levels. [11] [12] [13] More important, 2-level fusion can result in increased stress to the adjacent levels compared to 1-level fusion. 12, 13 These elevated stress levels are thought to contribute to early disc degeneration, osteophyte formation, and adjacent segment degeneration. Indeed, clinically symptomatic adjacent segment degeneration has been reported following cervical fusion. [14] [15] [16] Multilevel ACDF, especially with more than 2 fused levels, is more likely to result in pseudoarthrosis. 17 Finally, multilevel ACDF may result in more frequent and more extensive revision surgeries than single-level ACDF. 18 Increasing the number of arthroplasty levels is also not without possible consequences. The negative effect of imperfect device positioning and endplate-device matching would likely be amplified in multilevel CDA. 19, 20 The incidence of heterotopic ossification (HO) has been found to increase with the number of cervical arthroplasty levels without affecting patient-reported outcomes. 21, 22 Further and stronger long-term evidence is still needed in order to evaluate multilevel cervical surgeries. 20, 23 In an effort to establish the impact of increased surgical levels on the outcomes of both CDA and ACDF, a few studies have compared investigational and control arms within or across clinical trials so that 1-level CDA could be compared to 2-level CDA and 1-level ACDF compared to 2-level ACDF. [24] [25] [26] These studies indicated comparable outcomes for 1level and 2-level CDA but a decrease in efficacy from 1-level to 2-level ACDF. The purpose of this study is to compare outcomes of 1-level CDA to 2level CDA and of 1-level ACDF to 2-level ACDF at 2 and 7 years in a relatively large number of patients enrolled in clinical trials involving the same devices and the same efficacy and safety measures for both the 1-level and the 2-level studies, thereby adding to the body of evidence.
MATERIALS AND METHODS
The data of 2 previously conducted Food and Drug Administration-approved Investigational Device Exemption (IDE) clinical trials were combined and retrospectively analyzed. In the 1-level trial 27,28 (clinicaltrials.gov: NCT00667459), 280 nonrandomized patients were enrolled at 20 investigational sites and underwent 1-level CDA. The surgeries were performed between January and November 2005. The 280 CDA patients were compared to 265 historical control ACDF patients from a previous IDE study 1 The same device was used (PRESTIGE LP, Medtronic, Inc, Memphis, Tennessee) for the 1level and 2-level CDA surgeries. The same cortical ring allograft and anterior plate (Atlantis, Medtronic) was also used for both 1-level and 2-level ACDF standardized procedures.
Sample
To be included in one of these trials, patients had to have cervical degenerative disc disease at 1 or 2 adjacent levels involving intractable radiculopathy, myelopathy, or both. The presence of disc herniation and/or osteophyte responsible for nerve root and/or spinal cord compression had to be documented by patient history and radiographic studies.
Clinical Outcomes
As part of both protocols, patients completed the following questionnaires: the Neck Disability Index (NDI), 30 the Medical Outcomes Study Short Form Health Survey (SF-36), 31 and numerical rating scales (from 0 to 20 representing intensity þ frequency of pain) for neck pain and arm pain. 32 
Safety Outcomes
Neurological function was assessed by physicianconducted tests of motor, sensory, and reflex functions. Neurological success was achieved by the maintenance or improvement from preoperative status. An adverse event (AE) was defined as any clinical adverse sign, symptom, syndrome, or illness that occurred or worsened during the operative and postoperative periods. The severity of each AE was graded according to World Health Organization criteria (grades 1-4: mild, moderate, severe, lifethreatening), and the association of each AE with the implant or surgical procedure was assessed by an independent Clinical Adjudication Committee. Secondary surgical interventions were classified as either revision (adjustment or modification of the implant), removal (removal of implant or some of its components), supplemental fixation (placement of additional devices), or reoperation (any reoperation that is not a revision, removal, or supplemental fixation).
were met: (1) NDI score improvement of 15 points from preoperative score, (2) maintenance or improvement in neurological status from preoperative, (3) no serious AE caused by the implant or by both the implant and the surgical procedure, and (4) no additional surgery classified as supplemental fixation, revision, or nonelective implant removal.
Heterotopic Ossification
In 1-level and 2-level CDA subjects, HO was assessed on radiographs and graded according to the classification by Mehren et al 33 : 0 ¼ no HO present, I ¼ HO detectable in front of the vertebral body but not in the anatomical interdiscal space, II ¼ HO growing in the disc space and possibly affecting the function of the prosthesis, III ¼ bridging ossifications that still allow movement of the prosthesis, or IV ¼ complete fusion of treated segment without movement in flexion or extension.
Statistical Analyses
Statistical analyses were conducted with Statistical Analysis System (SAS Institute, Inc, Cary, North Carolina). To adjust for any possible effects of demographic characteristics or preoperative measures on clinical outcomes, the propensity score technique was used. The propensity score was calculated based on a logistic regression model with the following covariates: age, height, weight, sex, race, marital status, education level, work status, workers' compensation, spinal litigation, tobacco use, alcohol use, nonnarcotic pain medication use, weak narcotic pain medication use, strong narcotic pain medication use, muscle relaxant medication use, time to onset of symptoms, and previous neck surgery as well as treatment level and preoperative scores for NDI, SF-36 Physical Component Summary (PCS), SF-36 Mental Component Summary (MCS), neck pain, arm pain, gait, foraminal compression test reaction, and neurological status (motor function, sensory, and reflex). Covariate balance after propensity score adjustment was examined by using analysis of covariance (ANCOVA).
The outcome comparisons between groups were performed with ANCOVA adjusting for propensity score. The cumulative probabilities of AEs and secondary surgeries were derived from the life-table method and compared by using the PHREG procedure adjusting for propensity score. Nominal P values were reported without adjusting for comparisons of multiple outcomes and treatment groups.
RESULTS
A total of 942 patients were allocated as 489 CDA (280 1-level and 209 2-level) and 453 ACDF (265 1-level and 188 2-level). Table 1 reports the number of patients with overall success outcome data at each follow-up interval. By 7 years, the follow-up rates were 75.4% for 1-level CDA, 73.7% for 2-level CDA, 68.7% for 1-level ACDF, and 67.0% for 2-level ACDF. The demographic characteristics are reported in Table 2 . There were no significant differences between the groups after adjusting for the propensity score. The surgical characteristics are reported in Table 3 . The operating time was statistically longer for 2-level than 1level surgery for both CDA and ACDF. Estimated blood loss was statistically higher for 2-level CDA than 1-level CDA but not different between 1-level and 2-level ACDF.
Overall Success
There were no statistical differences in the rates of overall success between 1-level and 2-level CDA at any follow-up interval or between 1-level and 2-level ACDF (Table 4 ). Further, none of the individual components of overall success were statistically different between 1-level and 2-level CDA or 1-level and 2-level ACDF, with the exception of neurological success at 3 years for CDA.
Clinical Outcomes
There were no statistical differences in any of the patient-reported outcomes at any of the follow-up intervals between 1-level and 2-level procedures for either CDA or ACDF (Figure 1 ). All 4 groups exhibited a significant improvement from their preoperative scores and maintained this improve- Table 1 . Number of patients with overall success outcome data (percent follow-up) in the cervical disc arthroplasty (CDA) and anterior cervical discectomy and fusion (ACDF) groups. 
Number of Patients

Adverse Events
There were no statistical differences in the rates of implant-related AEs or serious implant-related AEs between 1-level and 2-level CDA ( Table 5 ). At longterm follow-up of 7 years, implant-related AE rates were 21.4% for 1-level and 26.6% for 2-level CDA, with rates of serious implant-related AEs of 6.5% and 3.2%, respectively. Although the rate of implant-related AEs at 7 years was higher for 2level ACDF (27.7%) than 1-level ACDF (18.9%) (P .036), the rates of serious implant-related AEs between 1-level and 2-level ACDF did not differ (at 7 years, 5.6% and 7.2% for 1-and 2-level, respectively) ( Table 5 ).
Secondary Surgeries
The rate of secondary surgeries was not statistically different between the 1-level and 2-level procedures for either CDA or ACDF (Table 6 ). This was the case for secondary surgeries at the index and adjacent levels at both 2 years and 7 years. In fact, at long-term follow-up of 7 years, the rate of secondary surgeries at adjacent levels trended slightly lower for 2-level than 1-level CDA (11.6% vs 6.5%, P .056). Table 7 shows occurrence of HO by grade at 2 and 7 years for 1-level and both superior and inferior levels of 2-level CDA. At 2 years, grade IV HO was reported in 1.2% of 1-level CDA patients and 2.0% and 3.0% at the superior and inferior levels in 2-level CDA patients. At 7 years, the rates of grade IV HO were 4.6% for 1-level and 8.6% and 7.3% for superior and inferior levels in 2-level CDA, respectively. Abbreviations: CDA, cervical disc arthroplasty; ACDF, anterior cervical discectomy and fusion; BMI, body mass index. *P values without adjusting for the propensity score: comparison between groups (analysis of covariance for continuous variables and Fisher exact test for categorical variables). Values listed in bold font are statistically significant. **P values after adjusting for the propensity score: comparison between groups (analysis of covariance for continuous variables and logistic regression for categorical variables, with propensity score as covariate). Abbreviations: CDA, cervical disc arthroplasty; ACDF, anterior cervical discectomy and fusion; EBL, estimated blood loss. *P values after adjusting for the propensity score for comparisons between groups by using analysis of covariance with propensity score as the covariate.
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1-Level Versus 2-Level Treatment With Cervical Disc Arthroplasty or Fusion
DISCUSSION
The patient groups included in this post hoc analysis belonged to separate clinical trials but met similar inclusion/exclusion criteria and underwent the same CDA or ACDF treatments, with the primary difference being 1-level versus 2-level pathology and treatment. Statistical methods were used to control for possible differences in preoperative patient characteristics of the 2 different trial groups. No statistical differences were found between 1-level and 2-level CDA for any measured outcomes. No differences were found between 1level and 2-level ACDF for overall success, all patient-reported outcomes, and secondary surgeries at the index and adjacent levels. Compared to 1level ACDF, 2-level ACDF had an increase in implant-related AEs at 7 years.
Patient-Reported Outcomes
Consistent with the results of the present study, other studies have reported noninferiority and sometimes superiority of patient-reported outcomes for multilevel CDA compared to single-level CDA. 21, 22, 24, 26, 34, 35 The current study found no statistical differences between the patient-reported outcomes of 1-level and 2-level ACDF. This is consistent with the results of Lee et al 36 but different from the comparison of the ACDF arms of the Mobi-C clinical trials, 25,26 which reported a decrease in NDI, PCS, and overall success for 2-level ACDF compared to 1-level ACDF.
Safety Outcomes
Studies have previously reported no increase in AEs or secondary surgeries with increasing CDA levels of treatment. 24, 26, 34, 35 Similarly, the comparison of the ACDF arms of the Mobi-C clinical trials found no difference in AEs or in secondary surgery rates between 1-level and 2-level ACDF. 25, 26 This is in contrast to Veeravagu et al, 18 who found that multilevel ACDF patients had an increased rate of reoperations. It is important to note that this latter study relied on an administrative database while the surgical procedures compared between the ACDF arms were standardized. The current study did not find a difference in the rate of secondary surgeries but found that 2-level ACDF appeared to have a higher rate of implant-related AEs at 7 years than 1level ACDF. Abbreviations: CDA, cervical disc arthroplasty; ACDF, anterior cervical discectomy and fusion; NDI, Neck Disability Index; AE, adverse event. *P values from logistic regression adjusting for propensity score. Success status was determined in patients with no missing data for Oswestry Disability Index, neurological, and disc height outcomes in addition to including as failures those with additional surgery (revision, removal, supplemental fixation) or serious device or device/procedure-associated adverse events at any interval, whether missing other data or not. One possible limitation of this study is that comparisons were made across separate clinical trials. The authors believe, however, that the statistical propensity score technique has provided sufficient control of confounding variables to present with confidence the results and conclusions of this study. The availability of certain data may limit the comparability of the present study to the results of other studies. Specifically, the current study did not measure either pseudarthrosis or adjacent segment degeneration in ACDF patients. Zigler et al 25 reported that the 6-month and 12month rate of nonunion was higher for 2-level ACDF than 1-level ACDF. This is consistent with previously reported higher pseudarthrosis rates with multilevel ACDF. [37] [38] [39] Zigler et al 25 also found no statistical difference in adjacent segment degeneration between 1-level and 2-level ACDF. To date, there is no conclusive evidence of the influence of number of fused cervical levels on adjacent segment degeneration. 40 Clinical trials, in general, have established CDA as a safe and effective alternative to ACDF in the treatment of cervical degenerative disease. The original 1-level IDE trial of the studied device reported similar improvement for CDA and ACDF at 2-and 7-year follow-up but with a statistically greater proportion of CDA patients achieving overall success (a composite endpoint of safety/efficacy) than ACDF patients at both 2-year and 7-year follow-up (74.9% CDA vs 63.2% ACDF). 27,28 Similarly, the 2level IDE trial also reported overall success superiority for CDA at 2-year (81.4% vs 69.4%) and 7-year follow-up (78.6% vs 62.7%). 8, 29 At 7 years, 2-level CDA also had fewer serious implant-related AEs (3.2% vs 7.2%) and fewer secondary surgeries at the index level (4.2% vs 14.7%) than 2-level ACDF. In addition to IDE clinical trials, evidence for the safety and effectiveness of multilevel CDA has also accumulated through studies comparing multilevel CDA to 1-level CDA 22, 24, 34, 35, [41] [42] [43] [44] and to multilevel Abbreviations: CDA, cervical disc arthroplasty; ACDF, anterior cervical discectomy and fusion; AEs, adverse events. *P values are obtained from the PHREG procedure using the likelihood ratio method adjusting for the propensity score. Cumulative probabilities are from the life-table estimation. Abbreviations: CDA, cervical disc arthroplasty; ACDF, anterior cervical discectomy and fusion. *P values are obtained from the PHREG procedure using the likelihood ratio method adjusting for the propensity score. Cumulative probabilities are from the life-table estimation.
ACDF. [45] [46] [47] Meta-analyses have confirmed the safety and effectiveness of multilevel arthroplasty. 23, 48 The current study, using data from highly similar clinical trials and with strong statistical control for possible differences in key preoperative subject characteristics between clinical trials, provides additional evidence suggesting that 1-and 2-level procedures provide similar efficacy and safety outcomes for patients being treated for cervical disc disease for both CDA and ACDF. These results are consistent with the majority of prior literature.
CONCLUSIONS
The present study determined that patients undergoing surgery for cervical disc disease at 2 adjacent cervical levels report similar improvement to patients undergoing surgery at just 1 cervical level after either CDA or ACDF. Safety profiles were also not significantly different between 1-and 2-level procedures, with just 1 exception: compared to 1level ACDF, 2-level ACDF had a greater proportion of device-related AEs at longer-term follow-up, though the difference between 1-and 2-level ACDF in serious device-related AEs was not significant.
